Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Anemia and cancer]

Jean-Philippe Spano¹, Moise Namer

¹Département d'Oncologie Médicale, Groupe Hospitalier Pitié-Salpêtrière, boulevard de l'Hôpital, 75 013 Paris.

Bulletin Du Cancer

|June 4, 2005

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

COVID-19 vaccination before immune checkpoint inhibitor initiation and the overall survival of patients with advanced cancer: A cohort study.

European journal of cancer (Oxford, England : 1990)·2026

Same author

[CANCERIMMUNE: A new INCa network designed to strengthen expertise in cancers of immunocompromised patients].

Bulletin du cancer·2026

Same author

A Response to the Letter to the Editor: "Re: 'Human Immunodeficiency Virus Impairs Immune Responses to Tumor Neoepitopes Without Altering Mutational Profiles in NSCLC'" by Gokhan Koker and Ozcelik.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026

Same author

Real-world outcomes of immune checkpoint inhibitors in people with HIV and skin cancer: a multicentre study.

The oncologist·2025

Same author

Multicenter Retrospective Analysis of the Safety and Efficacy of Sacituzumab Govitecan Combined With Radiation Therapy: The French ATTENTION Study.

International journal of radiation oncology, biology, physics·2025

Same author

Nivolumab in combination with ipilimumab versus capecitabine as post-operative treatment for triple negative breast cancer patients with residual disease after neoadjuvant chemotherapy: a multicentre, randomized, open-label phase II trial - BREASTIMMUNE-03.

Breast (Edinburgh, Scotland)·2025